Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma

EMT in carcinoma progression and dissemination: Facts, unanswered questions, and clinical considerations

(2012) Jeremy Bastid   CANCER AND METASTASIS REVIEWS

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

(2012) Gregg L. Semenza   TRENDS IN PHARMACOLOGICAL SCIENCES

Clinically Relevant Biomarkers to Select Patients for Targeted Inhibitor Therapy after Resection of Hepatocellular Carcinoma

(2011) Sameer H. Patel et al.   ANNALS OF SURGICAL ONCOLOGY

Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy

(2011) Riccardo Lencioni   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Therapeutic and prognostic importance of epithelial–mesenchymal transition in liver cancers: Insights from experimental models

(2011) Olorunseun O. Ogunwobi et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

(2011) Masatoshi Kudo et al.   EUROPEAN JOURNAL OF CANCER

Targeted Therapies for Hepatocellular Carcinoma

(2011) Augusto Villanueva et al.   GASTROENTEROLOGY

Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells under Hypoxic Conditions

(2011) Jae Young Choi et al.   Journal of Breast Cancer

TACE and Sorafenib: A Good Marriage?

(2011) Ghassan K. Abou-Alfa   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

(2011) Timothy M. Pawlik et al.   JOURNAL OF CLINICAL ONCOLOGY

Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma

(2010) Jongmin Kim et al.   CANCER SCIENCE

Overexpression of High-Mobility Group Box 2 Is Associated with Tumor Aggressiveness and Prognosis of Hepatocellular Carcinoma

(2010) J.-H. Kwon et al.   CLINICAL CANCER RESEARCH

Hepatocellular carcinoma: a global view

(2010) Ju Dong Yang et al.   Nature Reviews Gastroenterology & Hepatology

A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma

(2009) Wei-Ping Zhou et al.   ANNALS OF SURGERY

Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: Relevance of epithelial–mesenchymal transition

(2009) Liang Liu et al.   CANCER SCIENCE

The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes

(2009) King-Teh Lee et al.   JOURNAL OF SURGICAL ONCOLOGY

Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization

(2008) B. Wang et al.   ACTA RADIOLOGICA

Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness

(2008) Adriana Sergio et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Direct regulation of TWIST by HIF-1α promotes metastasis

(2008) Muh-Hwa Yang et al.   NATURE CELL BIOLOGY